|
is convenient to prepare and infuse
- Ready-to-use 10% solution requires no reconstitution; the use of an
in-line filter is optional1
- Flexible infusion rate of up to 5.0* mL/kg/hr can reduce infusion
time when appropriate
- Peel-off labels for patient charts
|
|
offers convenient packaging and storage
- Offered in 5 color-coded dosing sizes
- The only 10% IVIG solution with 9-month storage at room temperature** within 24 months of the date of processing
- 3-year storage when refrigerated***
|
|
GAMMAGARD LIQUID is indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity. These include but are not limited to congenital X-linked agammaglobulinemia, common variable immunodeficiency, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
Please see Important
Safety Information and Full
Prescribing Information for GAMMAGARD LIQUID [Immune
Globulin Intravenous (Human)] 10%
 |
To view PDFs, you will need
Adobe® Acrobat® Reader® software. |
§ 12-month trial among 61 patients with primary immunodeficiency.
* In a pivotal clinical trial§, mean infusion rate was 4.3 mL/kg/hr; 95% of subjects achieved a maximum rate of 4.0 mL/kg/hr or greater. Of these, 26% attained a rate of 5.0 mL/kg/hr.
** 25 C° (77° F)
*** 2° – 8° C (36°– 46° F)
1. GAMMAGARD LIQUID Immune Globulin Intravenous (Human) 10% [package insert].
Deerfield, IL. Baxter International Inc.; April 2005.
|
